Apnimed Raises $62.5M to Advance Lead Sleep Apnea Pill Candidate to Phase 3

Additional data from Apnimed’s Phase 2 MARIPOSA study later this year will inform the final design of the planned Phase 3 studies.

Related Keywords

Larry Miller ,Isaac Cheng ,Stefan Larson ,Gerald Chan ,Chris Dimitropoulos , ,Sectoral Asset Management ,Alpha Wave Ventures ,Morningside Ventures ,Seligman Investments ,Tao Capital ,Morningside Capital ,